Corcept Therapeutics (CORT) director Baker received 12,500 Stock Option (Right To Buy)
Insider transactions reported
G Leonard Baker Jr (director at Corcept Therapeutics Incorporated, CORT) reported that they received 12,500 Stock Option (Right To Buy) on May 21, 2026.
- Reporting person
- Baker G Leonard Jr
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| May 21, 2026 | Grant or award (A) | Stock Option (Right To Buy)On 12,500 Common Stock1 | +12,500 | - | - | 12,500 direct |
Holdings before and after
- Stock Option (Right To Buy): 0 to 12,500 direct
Footnotes from the filing
- 1. Exercisable ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period, subject to the Reporting Person's continued service on each monthly vesting date.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Baker report in this CORT Form 4?
G Leonard Baker Jr (director at Corcept Therapeutics Incorporated, CORT) reported that they received 12,500 Stock Option (Right To Buy) on May 21, 2026.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for CORT
Across the 18 sessions after earlier CORT headlines, the stock closed higher 11 times and lower 7 times, with a median move of 3.0% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
Earlier insider filings at CORT
- May 26, 2026SEC Form 4 filed by Director Alton Gregg H
- May 26, 2026SEC Form 4 filed by Director Wilson James N
- May 26, 2026SEC Form 4 filed by Director Swisher Daniel N Jr
- May 26, 2026SEC Form 4 filed by Director Murray Joshua M.
- May 26, 2026SEC Form 4 filed by Director Mahoney David L
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Listed since
- 2004
Follow CORT and get a push notification the moment its next story breaks.